Olmsted syndrome
- PMID: 23320205
- PMCID: PMC3540698
- DOI: 10.1155/2012/927305
Olmsted syndrome
Abstract
Olmsted syndrome is a rare congenital, sharply circumscribed transgredient palmoplantar keratoderma. It was first described by Olmsted in 1927. The diagnosis of this rare disease depends on clinical features like symmetrical involvement of keratoderma of the palms and soles and the symmetrical hyperkeratotic plaques around the body orifices. It starts in the neonatal period or in childhood. The disease has a slow but progressive and extremely disabling course. Treatment of Olmsted syndrome is often based on topical therapy with retinoic acid, corticosteroid, emollients, and keratolytics. The present paper describes a case of Olmsted syndrome and its treatment.
Figures
Comment in
-
Comment on "Olmsted Syndrome".Case Rep Dermatol Med. 2020 Jun 3;2020:8024981. doi: 10.1155/2020/8024981. eCollection 2020. Case Rep Dermatol Med. 2020. PMID: 32566327 Free PMC article. No abstract available.
References
-
- Fonseca E, Peña C, Del Pozo J, et al. Olmsted syndrome. Journal of Cutaneous Pathology. 2001;28(5):271–275. - PubMed
-
- Frias-Iniesta J, Sanchez-Pedreño P, Martinez-Escribano JA, Jimenez-Martinez A. Olmsted syndrome: report of a new case. British Journal of Dermatology. 1997;136(6):935–938. - PubMed
-
- Bergonse FN, Rabello SM, Barreto RL, et al. Olmsted syndrome: the clinical spectrum of mutilating palmoplantar keratoderma. Pediatric Dermatology. 2003;20(4):323–326. - PubMed
-
- Tao J, Huang CZ, Yu NW, et al. Olmsted syndrome: a case report and review of literature. International Journal of Dermatology. 2008;47(5):432–437. - PubMed
LinkOut - more resources
Full Text Sources
